Intimation of Schedule of analyst or institutional investor meetings
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krishna Institute of Medical Sciences Limited (KIMS) has notified the stock exchanges about scheduled one-on-one and group meetings with investors and analysts from May 25-29, 2026. The meetings will be conducted through video calls, phone calls, or in-person. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during these interactions, and discussions will be limited to general business outlook and publicly available information. The schedule may be subject to change due to operational exigencies. This filing is made under Regulation 30 of the SEBI Listing Regulations.
This is a routine investor relations disclosure indicating active engagement with institutional investors and analysts. It promotes transparency but contains no specific investment insights or price-sensitive details. No direct impact on stock price is expected from this announcement.